IGMS240920C30000
- 0.05
- -0.65-92.86%
IGM Biosciences Newsroom
IGM Biosciences Executive Sells Over $17k in Company Stock
Will IGM Biosciences (NASDAQ:IGMS) Spend Its Cash Wisely?
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
IGM Biosciences Is Maintained at Neutral by HC Wainwright & Co.
H.C. Wainwright Maintains IGM Biosciences(IGMS.US) With Hold Rating, Cuts Target Price to $11
H.C. Wainwright analyst Robert Burns maintains $IGM Biosciences(IGMS.US)$ with a hold rating, and adjusts the target price from $12 to $11.According to TipRanks data, the analyst has a success rate
IGM Biosciences: Hold Rating Affirmed Amid Financial Challenges and Clinical Catalysts
Truist Financial Maintains IGM Biosciences(IGMS.US) With Buy Rating, Announces Target Price $24
Truist Financial analyst Asthika Goonewardene maintains $IGM Biosciences(IGMS.US)$ with a buy rating, and sets the target price at $24.According to TipRanks data, the analyst has a success rate of 40.
Truist Financial Reaffirms Their Buy Rating on IGM Biosciences (IGMS)
Express News | IGM Biosciences Inc : Truist Securities Cuts Target Price to $24 From $25
All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy
Truist Securities Trims Price Target on IGM Biosciences to $24 From $25, Maintains Buy Rating
IGM Biosciences Price Target Raised to $25.00/Share From $20.00 by Wedbush
IGM Biosciences Is Maintained at Outperform by Wedbush
IGM Biosciences Shares Are Trading Higher. JP Morgan Raised Its Price Target on the Stock From $11 to $12.
Wedbush Maintains IGM Biosciences(IGMS.US) With Buy Rating, Raises Target Price to $25
Wedbush analyst Robert Driscoll maintains $IGM Biosciences(IGMS.US)$ with a buy rating, and adjusts the target price from $20 to $25.According to TipRanks data, the analyst has a success rate of 40.3%
Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS)
JP Morgan Maintains Neutral on IGM Biosciences, Raises Price Target to $12
IGM Biosciences Analyst Ratings
J.P. Morgan Maintains IGM Biosciences(IGMS.US) With Hold Rating, Raises Target Price to $12
J.P. Morgan analyst Eric Joseph maintains $IGM Biosciences(IGMS.US)$ with a hold rating, and adjusts the target price from $11 to $12.According to TipRanks data, the analyst has a success rate of 49.7